Abstract

The ATR-CHK1 DNA damage response pathway becomes activated by the exposure of RPA-coated single-stranded DNA (ssDNA) that forms as an intermediate during DNA damage and repair, and as a part of the replication stress response. Here, we identify ZNF827 as a component of the ATR-CHK1 kinase pathway. We demonstrate that ZNF827 is a ssDNA binding protein that associates with RPA through concurrent binding to ssDNA intermediates. These interactions are dependent on two clusters of C2H2 zinc finger motifs within ZNF827. We find that ZNF827 accumulates at stalled forks and DNA damage sites, where it activates ATR and promotes the engagement of homologous recombination-mediated DNA repair. Additionally, we demonstrate that ZNF827 depletion inhibits replication initiation and sensitizes cancer cells to the topoisomerase inhibitor topotecan, revealing ZNF827 as a therapeutic target within the DNA damage response pathway.

Here, the authors characterise the zinc finger protein ZNF827 as a single stranded DNA binding protein that accumulates at stalled replication forks to activate the ATR-CHK1 pathway and engage homologous-recombination mediated DNA repair.

Details

Title
ZNF827 is a single-stranded DNA binding protein that regulates the ATR-CHK1 DNA damage response pathway
Author
Yang, Sile F. 1 ; Nelson, Christopher B. 1 ; Wells, Jadon K. 1   VIAFID ORCID Logo  ; Fernando, Madushan 1 ; Lu, Robert 1 ; Allen, Joshua A. M. 1 ; Malloy, Lisa 1 ; Lamm, Noa 2 ; Murphy, Vincent J. 3   VIAFID ORCID Logo  ; Mackay, Joel P. 4   VIAFID ORCID Logo  ; Deans, Andrew J. 5   VIAFID ORCID Logo  ; Cesare, Anthony J. 6   VIAFID ORCID Logo  ; Sobinoff, Alexander P. 1   VIAFID ORCID Logo  ; Pickett, Hilda A. 1   VIAFID ORCID Logo 

 University of Sydney, Telomere Length Regulation Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 University of Sydney, Nuclear Dynamics Group, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 St Vincent’s Institute, Genome Stability Unit, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X) 
 University of Sydney, School of Life and Environmental Sciences, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
 St Vincent’s Institute, Genome Stability Unit, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine (St Vincent’s), Fitzroy, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 University of Sydney, Genome Integrity Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X) 
Pages
2210
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2955977752
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.